{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:48:48Z","timestamp":1791179328846,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[1999,2,26]],"date-time":"1999-02-26T00:00:00Z","timestamp":919987200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[1999,3]]},"DOI":"10.1038\/sj.bjc.6690245","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T14:04:07Z","timestamp":1032271447000},"page":"1534-1541","source":"Crossref","is-referenced-by-count":37,"title":["Comparison of immunohistochemistry with immunoassay (ELISA) for the detection of components of the plasminogen activation system in human tumour tissue"],"prefix":"10.1038","volume":"79","author":[{"given":"C M","family":"Ferrier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H H de","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Straatman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D H van","family":"Tienoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W L van","family":"Geloof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F J R","family":"Rietveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C G J","family":"Sweep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D J","family":"Ruiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G N P van","family":"Muijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[1999,2,26]]},"reference":[{"key":"BF6690245_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z","volume":"72","author":"PA Andreasen","year":"1997","unstructured":"Andreasen, P. A., Kj\u00f8ller, L., Christensen, L. & Duffy, M. J. (1997). The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72: 1\u201322.","journal-title":"Int J Cancer"},{"key":"BF6690245_CR2","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1016\/S0021-9258(19)39348-2","volume":"265","author":"N Behrendt","year":"1990","unstructured":"Behrendt, N., R\u00f8nne, E., Ploug, M., Petri, T., L\u00f8ber, D., Nielsen, L. S., Schleuning, W-D, Blasi, F., Appella, E. & Dan\u00f8, K. (1990). The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. J Biol Chem 265: 6453\u20136460.","journal-title":"J Biol Chem"},{"key":"BF6690245_CR3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248\u2013254.","journal-title":"Anal Biochem"},{"key":"BF6690245_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/(SICI)1097-0215(19960516)66:4<441::AID-IJC6>3.0.CO;2-W","volume":"66","author":"L Christensen","year":"1996","unstructured":"Christensen, L., Wiborg Simonsen, A. C., Heegaard, C. W., Moestrup, S. K., Andersen, J. A. & Andreasen, P. A. (1996). Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and \u03b12-macroglobulin receptor in human breast carcinomas. Int J Cancer 66: 441\u2013452.","journal-title":"Int J Cancer"},{"key":"BF6690245_CR5","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S0344-0338(96)80094-X","volume":"192","author":"TJ de Vries","year":"1996","unstructured":"de Vries, T. J., van Muijen, G. N. P. & Ruiter, D. J. (1996). The plasminogen activation system in tumour invasion and metastasis. Path Res Pract 192: 718\u2013733.","journal-title":"Path Res Pract"},{"key":"BF6690245_CR6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/(SICI)1097-0215(19970729)72:3<416::AID-IJC8>3.0.CO;2-S","volume":"72","author":"H de Witte","year":"1997","unstructured":"de Witte, H., Pappot, H., Br\u00fcnner, N., Gr\u00f8ndahl-Hansen, J., H\u00f8yer-Hansen, G., Behrendt, N., Guldhammer-Skov, B., Sweep, F., Benraad, T. & Dan\u00f8, K. (1997). ELISA for complexes between urokinase-type plasminogen activator and its receptor in lung cancer tissue extracts. Int J Cancer 72: 416\u2013423.","journal-title":"Int J Cancer"},{"key":"BF6690245_CR7","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/ijc.2910610502","volume":"61","author":"C Duggan","year":"1995","unstructured":"Duggan, C., Maguire, T., McDermott, E., O\u2019Higgins, N., Fennelly, J. J. & Duffy, M. J. (1995). Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. Int J Cancer 61: 597\u2013600.","journal-title":"Int J Cancer"},{"key":"BF6690245_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1177\/002215549804600406","volume":"46","author":"CM Ferrier","year":"1998","unstructured":"Ferrier, C. M., van Geloof, W. L., de Witte, J. H., Kramer, M. D., Ruiter, D. J. & van Muijen, G. N. P. (1998). Epitopes of components of the plasminogen activation system are re-exposed in formalin-fixed paraffin sections by different retrieval techniques. J Histochem Cytochem 46: 469\u2013476.","journal-title":"J Histochem Cytochem"},{"key":"BF6690245_CR9","first-page":"1423","volume":"55","author":"JA Foekens","year":"1995","unstructured":"Foekens, J. A., Buessecker, F., Peters, H. A., Krainick, U., van Putten, W. L. J., Look, M. P., Klijn, J. G. M. & Kramer, M. D. (1995). Plasminogen activator inhibitor-2: prognostic relevance in 1012 patients with primary breast cancer. Cancer Res 55: 1423\u20131427.","journal-title":"Cancer Res"},{"key":"BF6690245_CR10","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/(SICI)1097-0142(19960315)77:6<1035::AID-CNCR5>3.0.CO;2-G","volume":"77","author":"S Ganesh","year":"1996","unstructured":"Ganesh, S., Sier, C. F. M., Heerding, M. M., van Krieken, J.H.J.M., Griffioen, G., Welvaart, K., van de Velde, C. J. H., Verheijen, J. H., Lamers, C.B.H.W. & Verspaget, H. W. (1996). Prognostic value of the plasminogen activation system in patients with gastric carcinoma. Cancer 77: 1035\u20131043.","journal-title":"Cancer"},{"key":"BF6690245_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/172460089701200102","volume":"12","author":"N Grebenschikov","year":"1997","unstructured":"Grebenschikov, N., Geurts-Moespot, A., de Witte, H., Heuvel, J., Leake, R., Sweep, F. & Benraad, T. (1997). A sensitive and robust assay for urokinase and tissue-type plasminogen activators (uPA and tPA) and their inhibitor type I (PAI-1) in breast tumor cytosols. Int J Biol Markers 12: 6\u201314.","journal-title":"Int J Biol Markers"},{"key":"BF6690245_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0748-7983(96)91649-2","volume":"22","author":"MM Heiss","year":"1996","unstructured":"Heiss, M. M., Babic, R., Allgayer, H., Gruetzner, K. U., Jauch, K-W, Loehrs, U. & Schildberg, F. W. (1996). The prognostic impact of the urokinase-type plasminogen activator system is associated with tumour differentiation in gastric cancer. Eur J Surg Oncol 22: 74\u201377.","journal-title":"Eur J Surg Oncol"},{"key":"BF6690245_CR13","first-page":"114","volume":"147","author":"DW Hsu","year":"1995","unstructured":"Hsu, D. W., Efird, J. T. & Hedley-Whyte, E. T. (1995). Prognostic role of urokinase-type plasminogen activator in human gliomas. Am J Pathol 147: 114\u2013123.","journal-title":"Am J Pathol"},{"key":"BF6690245_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0268-9499(90)90001-Z","volume":"4","author":"F J\u00e4nicke","year":"1990","unstructured":"J\u00e4nicke, F., Schmitt, M., Hafter, R., Hollrieder, A., Babic, R., Ulm, K., G\u00f6ssner, W. & Graeff, H. (1990). Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer. Fibrinolysis 4: 69\u201378.","journal-title":"Fibrinolysis"},{"key":"BF6690245_CR15","first-page":"6539","volume":"54","author":"H Kobayashi","year":"1994","unstructured":"Kobayashi, H., Fujishiro, S. & Terao, T. (1994). Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus. Cancer Res 54: 6539\u20136548.","journal-title":"Cancer Res"},{"key":"BF6690245_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1006\/gyno.1994.1313","volume":"55","author":"W Kuhn","year":"1994","unstructured":"Kuhn, W., Pache, L., Schmalfeldt, B., Dettmar, P., Schmitt, M., J\u00e4nicke, F. & Graeff, H. (1994). Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy. Gynecol Oncol 55: 401\u2013409.","journal-title":"Gynecol Oncol"},{"key":"BF6690245_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0140-6736(94)91968-2","volume":"344","author":"HE Mulcahy","year":"1994","unstructured":"Mulcahy, H. E., Duffy, M. J., Gibbons, D., McCarthy, P., Parfrey, N. A., O\u2019Donoghue, D. P. & Sheahan, K. (1994). Urokinase-type plasminogen activator and outcome in Dukes\u2019 B colorectal cancer. Lancet 344: 583\u2013584.","journal-title":"Lancet"},{"key":"BF6690245_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0169-5002(97)00032-9","volume":"17","author":"H Pappot","year":"1997","unstructured":"Pappot, H., Guldhammer Skov, B., Pyke, C. & Gr\u00f8ndahl-Hansen, J. (1997). Levels of plasminogen activator inhibitor type 1 and urokinase plasminogen activator receptor in non-small cell lung cancer as measured by quantitative ELISA and semiquantitative immunohistochemistry. Lung Cancer 17: 197\u2013209.","journal-title":"Lung Cancer"},{"key":"BF6690245_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0014-5793(91)81042-7","volume":"288","author":"E R\u00f8nne","year":"1991","unstructured":"R\u00f8nne, E., Behrendt, N., Ellis, V., Ploug, M., Dan\u00f8, K. & H\u00f8yer-Hansen, G. (1991). Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor. FEBS Lett 288: 233\u2013236.","journal-title":"FEBS Lett"},{"key":"BF6690245_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF00665944","volume":"33","author":"E R\u00f8nne","year":"1995","unstructured":"R\u00f8nne, E., H\u00f8yer-Hansen, G., Br\u00fcnner, N., Pederson, H., Rank, F., Osborne, C. K., Clark, G. M., Dan\u00f8, K. & Gr\u00f8ndahl-Hansen, J. (1995). Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies. Breast Cancer Res Treat 33: 199\u2013207.","journal-title":"Breast Cancer Res Treat"},{"key":"BF6690245_CR21","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/S0959-8049(98)00151-8","volume":"34","author":"DJ Ruiter","year":"1998","unstructured":"Ruiter, D. J., Ferrier, C. M., van Muijen, G. N. P., Henzen-Logmans, S. C., Kennedy, S., Kramer, M. D., Nielsen, B. S. & Schmitt, M. (1998). Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related components. Eur J Cancer 34: 1334\u20131340.","journal-title":"Eur J Cancer"},{"key":"BF6690245_CR22","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/bjc.1997.383","volume":"76","author":"M Schmitt","year":"1997","unstructured":"Schmitt, M., Thomssen, C., Ulm, K., Seiderer, A., Harbeck, N., H\u00f6fler, H., J\u00e4nicke, F. & Graeff, H. (1997). Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer. Br J Cancer 76: 306\u2013311.","journal-title":"Br J Cancer"},{"key":"BF6690245_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1365-2559.1991.tb00027.x","volume":"19","author":"CFM Sier","year":"1991","unstructured":"Sier, C. F. M., Fellbaum, C., Verspaget, H. W., Schmitt, M., Griffioen, G., Graeff, H., H\u00f6fler, H. & Lamers, C.B.H.W. (1991). Immunolocalization of urokinase-type plasminogen activator in adenomas and carcinomas of the colorectum. Histopathology 19: 231\u2013237.","journal-title":"Histopathology"},{"key":"BF6690245_CR24","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/bjc.1998.704","volume":"78","author":"CGJ Sweep","year":"1998","unstructured":"Sweep, C. G. J., Geurts-Moespot, J., Grebenschikov, N., de Witte, J. H., Heuvel, J.J.T.M., Schmitt, M., Duffy, M. J., J\u00e4nicke, F., Kramer, M. D., Foekens, J. A., Br\u00fcnner, N., Brugal, G., Pedersen, A. N. & Benraad, T. J. (1998). External quality assessment of trans-European multicentre antigen determinations (Enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts. Br J Cancer 78: 1434\u20131441.","journal-title":"Br J Cancer"},{"key":"BF6690245_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/BF01806378","volume":"9","author":"SM Thorpe","year":"1987","unstructured":"Thorpe, S. M. (1987). Steroid receptors in breast cancer: sources of inter-laboratory variation in dextran-charcoal assays. Breast Cancer Res Treat 9: 175\u2013189.","journal-title":"Breast Cancer Res Treat"},{"key":"BF6690245_CR26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<388::AID-PATH943>3.0.CO;2-I","volume":"183","author":"T Umeda","year":"1997","unstructured":"Umeda, T., Eguchi, Y., Okino, K., Kodama, M. & Hattori, T. (1997). Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues. J Pathol 183: 388\u2013397.","journal-title":"J Pathol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6690245.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690245","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690245.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:51:32Z","timestamp":1684414292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6690245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2,26]]},"references-count":26,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["BF6690245"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6690245","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2,26]]}}}